Reference : Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkins...
Scientific journals : Article
Life sciences : Genetics & genetic processes
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.
Elbaz, Alexis [> >]
Nelson, Lorene M. [> >]
Payami, Haydeh [> >]
Ioannidis, John P. A. [> >]
Fiske, Brian K. [> >]
Annesi, Grazia [> >]
Carmine Belin, Andrea [> >]
Factor, Stewart A. [> >]
Ferrarese, Carlo [> >]
Hadjigeorgiou, Georgios M. [> >]
Higgins, Donald S. [> >]
Kawakami, Hideshi [> >]
Krüger, Rejko mailto [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit]
Marder, Karen S. [> >]
Mayeux, Richard P. [> >]
Mellick, George D. [> >]
Nutt, John G. [> >]
Ritz, Beate [> >]
Samii, Ali [> >]
Tanner, Caroline M. [> >]
Van Broeckhoven, Christine [> >]
Van Den Eeden, Stephen K. [> >]
Wirdefeldt, Karin [> >]
Zabetian, Cyrus P. [> >]
Dehem, Marie [> >]
Montimurro, Jennifer S. [> >]
Southwick, Audrey [> >]
Myers, Richard M. [> >]
Trikalinos, Thomas A. [> >]
Lancet Neurology
Yes (verified by ORBilu)
[en] Aged ; Confidence Intervals ; Female ; Genetic Predisposition to Disease ; Humans ; International Cooperation ; Linkage Disequilibrium ; Male ; Meta-Analysis as Topic ; Middle Aged ; Odds Ratio ; Parkinson Disease/epidemiology/genetics ; Polymorphism, Single Nucleotide/genetics
[en] BACKGROUND: A genome-wide association study identified 13 single-nucleotide polymorphisms (SNPs) significantly associated with Parkinson's disease. Small-scale replication studies were largely non-confirmatory, but a meta-analysis that included data from the original study could not exclude all SNP associations, leaving relevance of several markers uncertain. METHODS: Investigators from three Michael J Fox Foundation for Parkinson's Research-funded genetics consortia-comprising 14 teams-contributed DNA samples from 5526 patients with Parkinson's disease and 6682 controls, which were genotyped for the 13 SNPs. Most (88%) participants were of white, non-Hispanic descent. We assessed log-additive genetic effects using fixed and random effects models stratified by team and ethnic origin, and tested for heterogeneity across strata. A meta-analysis was undertaken that incorporated data from the original genome-wide study as well as subsequent replication studies. FINDINGS: In fixed and random-effects models no associations with any of the 13 SNPs were identified (odds ratios 0.89 to 1.09). Heterogeneity between studies and between ethnic groups was low for all SNPs. Subgroup analyses by age at study entry, ethnic origin, sex, and family history did not show any consistent associations. In our meta-analysis, no SNP showed significant association (summary odds ratios 0.95 to 1.08); there was little heterogeneity except for SNP rs7520966. INTERPRETATION: Our results do not lend support to the finding that the 13 SNPs reported in the original genome-wide association study are genetic susceptibility factors for Parkinson's disease.
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group)

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.